Sinem Güngör, Özlem Ediboğlu, Özlem Yazıcıoğlu Moçin, Nalan Adıgüzel, Eylem Tuncay, İnşa Gül Ekiz İşcanlı, Berrin Er, Zuhal Karakurt, Sema Turan, Behiye Deniz Kosovalı, Nevzat Mehmet Mutlu, Duygu Kayar, Şerife Gökbulut Bektaş, Elmas Uysal, Fatih Seğmen, Gürayalp Alp, Deniz Erdem, Nazan Has Selmi, Pınar Güven, Zerrin Özçelik, Merve Ocakcıoğlu, Canan Yazıcı Özgür, Rabia Yılmaz, Deniz Bilgi Özel, Halil Cebeci, Bahar Güler, Canan Cansever, Mehmet Çakırca, Hansa İnceöz, İlker Solmaz, Fatma Özkan Sipahioğlu, Eda Macit Aydın, Hakan Dayanır, Sait Fatih Öner, Umut Karatepe, Serkan Özen, Maruf Boran, Dursun Fırat Ergül, Umut Sabri Kasapoğlu, Leman Acun Delen, Erol Toy, Koray Altun, Tuna Albayrak, Hülya Yanal, Gizem Zaim, Volkan Yarar, Gökhan Kılınç, Mustafa Deniz, Esra Özdemir, Veysel Garani Soylu, Ayşe Yılmaz, Saba Mukaddes Saygılı, Ejder Kamil Öztürk, Begüm Ergan, Selin Eyüpoğlu, Yiğit Şahin, Beyza Yüksel, Azime Bulut, Aykut Sarıtaş, Hicret Yeniay, Mürşide Genç, Feyza Kargın, Osman Özcan, Ebru Karakoç, Ümran Karaca, Didem Sözütek, Sema Sarı, Nimet Şenoğlu, Hakan Aygün, Arzu Ceren Yiğit, Nilgün Kavruk, Çağdaş Alp Uzan, Murat Bıçakcıoğlu, Serkan Solak, Hatice Kutbay Özçelik, Kamuran Uluç, İlker Yıldırım, Makbule Cavidan Arar, İsmail Demirel, Soner Umut Küver, Eylem Sercan Özgür, Kutlay Aydın, Gül Erdal Dönmez, Gülbin Aygencel, Aliye Esmaoğlu, Berrak Sebil Aydın, Murat Emre Tokur, Pervin Korkmaz Ekren, Yusuf Aydemir, Başak Çakır Güney, Ömer Yavuz Erdil, Abdurrahman Tünay, Türkan Bahadır, Serkan Uçkun, Nazan Kocaoğlu, Hüseyin Ulaş Pınar, Nurcan Kutluer Karaca, Hamza Gültekin, Pınar Ayvat, Ayşe Belin Özer, Ahmet Eroğlu, Ufuk Kuyrukluyıldız, Çağdaş Baytar, Hilal Ayoğlu, Serpil Mızrakçı, Hatice Metin, Özgecan Pırıl Zanbak Mutlu, Hakan Yılmaz, Filiz Tüzüner
{"title":"Evaluation of Patients with COVID-19 Followed Up in Intensive Care Units in the Second Year of the Pandemic: A Multicenter Point Prevalence Study.","authors":"Sinem Güngör, Özlem Ediboğlu, Özlem Yazıcıoğlu Moçin, Nalan Adıgüzel, Eylem Tuncay, İnşa Gül Ekiz İşcanlı, Berrin Er, Zuhal Karakurt, Sema Turan, Behiye Deniz Kosovalı, Nevzat Mehmet Mutlu, Duygu Kayar, Şerife Gökbulut Bektaş, Elmas Uysal, Fatih Seğmen, Gürayalp Alp, Deniz Erdem, Nazan Has Selmi, Pınar Güven, Zerrin Özçelik, Merve Ocakcıoğlu, Canan Yazıcı Özgür, Rabia Yılmaz, Deniz Bilgi Özel, Halil Cebeci, Bahar Güler, Canan Cansever, Mehmet Çakırca, Hansa İnceöz, İlker Solmaz, Fatma Özkan Sipahioğlu, Eda Macit Aydın, Hakan Dayanır, Sait Fatih Öner, Umut Karatepe, Serkan Özen, Maruf Boran, Dursun Fırat Ergül, Umut Sabri Kasapoğlu, Leman Acun Delen, Erol Toy, Koray Altun, Tuna Albayrak, Hülya Yanal, Gizem Zaim, Volkan Yarar, Gökhan Kılınç, Mustafa Deniz, Esra Özdemir, Veysel Garani Soylu, Ayşe Yılmaz, Saba Mukaddes Saygılı, Ejder Kamil Öztürk, Begüm Ergan, Selin Eyüpoğlu, Yiğit Şahin, Beyza Yüksel, Azime Bulut, Aykut Sarıtaş, Hicret Yeniay, Mürşide Genç, Feyza Kargın, Osman Özcan, Ebru Karakoç, Ümran Karaca, Didem Sözütek, Sema Sarı, Nimet Şenoğlu, Hakan Aygün, Arzu Ceren Yiğit, Nilgün Kavruk, Çağdaş Alp Uzan, Murat Bıçakcıoğlu, Serkan Solak, Hatice Kutbay Özçelik, Kamuran Uluç, İlker Yıldırım, Makbule Cavidan Arar, İsmail Demirel, Soner Umut Küver, Eylem Sercan Özgür, Kutlay Aydın, Gül Erdal Dönmez, Gülbin Aygencel, Aliye Esmaoğlu, Berrak Sebil Aydın, Murat Emre Tokur, Pervin Korkmaz Ekren, Yusuf Aydemir, Başak Çakır Güney, Ömer Yavuz Erdil, Abdurrahman Tünay, Türkan Bahadır, Serkan Uçkun, Nazan Kocaoğlu, Hüseyin Ulaş Pınar, Nurcan Kutluer Karaca, Hamza Gültekin, Pınar Ayvat, Ayşe Belin Özer, Ahmet Eroğlu, Ufuk Kuyrukluyıldız, Çağdaş Baytar, Hilal Ayoğlu, Serpil Mızrakçı, Hatice Metin, Özgecan Pırıl Zanbak Mutlu, Hakan Yılmaz, Filiz Tüzüner","doi":"10.5152/ThoracResPract.2023.23024","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>A 1-day point prevalence study was planned to obtain country data by determining the clinical characteristics, follow-up and treatment methods of coronavirus disease 2019 (COVID-19) cases that required intensive care unit (ICU) treatment in the second year of the pandemic.</p><p><strong>Material and methods: </strong>All patients who were hospitalized in the ICUs due to COVID-19 between March 11, 2022, 08.00 am, and March 12, 2022, 08.00 am, were included in the study. Demographic characteristics, intensive care and laboratory data, radiological characteristics, and follow-up results of the patients were recorded.</p><p><strong>Results: </strong>A total of 811 patients from 59 centers were included in the study, 59% of the cases were male, and the mean age was 74 ± 14 years. At least one comorbid disease was present in 94% of the cases, and hypertension was the most common. When ICU weight scores were examined, Acute Physiology and Chronic Health Evaluation-II: 19 (15-27) and Sequential Organ Failure Assessment: 7 (4-10) were seen. Sepsis was present in 37% (n = 298) of cases. PaO2/FiO2 ratios of the patients were 190 the highest and 150 the lowest and 51% of the cases were followed via invasive mechanical ventilation. On the study day, 73% bilateral involvement was seen on chest x-ray, and ground-glass opacities (52%) were the most common on chest tomography. There was growth in culture in 40% (n = 318) of the cases, and the most common growth was in the tracheal aspirate (42%).</p><p><strong>Conclusion: </strong>The clinical course of COVID-19 is variable, and ICU follow-up was required due to advanced age, comorbidity, presence of respiratory symptoms, and widespread radiological involvement. The need for respiratory support and the presence of secondary infection are important issues to be considered in the follow-up. Despite the end of the second year of the pandemic and vaccination, the high severity of the disease as well as the need for follow-up in ICUs has shown that COVID-19 is an important health problem.COVID-19, intensive care, intensive care unit, pandemic, follow-up</p>","PeriodicalId":75221,"journal":{"name":"Thoracic research and practice","volume":" ","pages":"11 - 16"},"PeriodicalIF":0.6000,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11160344/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thoracic research and practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5152/ThoracResPract.2023.23024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"0","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: A 1-day point prevalence study was planned to obtain country data by determining the clinical characteristics, follow-up and treatment methods of coronavirus disease 2019 (COVID-19) cases that required intensive care unit (ICU) treatment in the second year of the pandemic.
Material and methods: All patients who were hospitalized in the ICUs due to COVID-19 between March 11, 2022, 08.00 am, and March 12, 2022, 08.00 am, were included in the study. Demographic characteristics, intensive care and laboratory data, radiological characteristics, and follow-up results of the patients were recorded.
Results: A total of 811 patients from 59 centers were included in the study, 59% of the cases were male, and the mean age was 74 ± 14 years. At least one comorbid disease was present in 94% of the cases, and hypertension was the most common. When ICU weight scores were examined, Acute Physiology and Chronic Health Evaluation-II: 19 (15-27) and Sequential Organ Failure Assessment: 7 (4-10) were seen. Sepsis was present in 37% (n = 298) of cases. PaO2/FiO2 ratios of the patients were 190 the highest and 150 the lowest and 51% of the cases were followed via invasive mechanical ventilation. On the study day, 73% bilateral involvement was seen on chest x-ray, and ground-glass opacities (52%) were the most common on chest tomography. There was growth in culture in 40% (n = 318) of the cases, and the most common growth was in the tracheal aspirate (42%).
Conclusion: The clinical course of COVID-19 is variable, and ICU follow-up was required due to advanced age, comorbidity, presence of respiratory symptoms, and widespread radiological involvement. The need for respiratory support and the presence of secondary infection are important issues to be considered in the follow-up. Despite the end of the second year of the pandemic and vaccination, the high severity of the disease as well as the need for follow-up in ICUs has shown that COVID-19 is an important health problem.COVID-19, intensive care, intensive care unit, pandemic, follow-up
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
